About ECRON AcuNova   Vision and Quality policy   Letter from Leaders      Letter from Vice Chairman      Letter from President   The Team   Fact sheet     About ECRON AcuNova ECRON AcuNova provides end-to-end services for Phase I - IV clinical research including Clinical Trial Management, Clinical Data Management, PK/PD services and Central Lab. ECRON AcuNova has research facilities in India as well as an established presence in various parts of Europe and in United States. As regional experts, we operate each Region as a priority market. We have European HQ at Frankfurt, United States HQ at Princeton and Asian HQ at Bangalore.   ECRON ACUNOVA CREATES VALUE BY  Delivering quality on time within budget with personalized services, through an intelligent combination of    capabilities and resources.  Knowledge based on 21 years experience in clinical research with established presence in different parts of    Europe, Asia and America facilitating deep regional knowledge.   HIGHLIGHTS  Expertise to conduct Phase I-IV research for Pharma, Biotech, Phyto and Device sponsors.  Enhanced control over Study Management as a Full Service CRO - from protocol to study report. We have in    house: Central Lab, Clinical Data Management, Bio Statistics, Medical Writing and Regulatory Consulting    services.  Faster enrolment with access to a large patient pool matching demographics of large markets. For example,     we have preferred access to 19 teaching hospitals of Manipal University -Asia's largest academic medical     centre treating 1.5 mn patients with more than 1500 physicians. With privileged access, we are able to     provide to site, SMO services to improve the research productivity of Investigators.  We have experience in conducting studies with imaging and biomarker end points. Our Central lab has     molecular diagnostic capability giving pharmaco-genomic insight. We are equipped to work with e-CRF's and    can prepare e-CTD. These help in early availability of CSR.  Our direct presence in a new clinical research geography like India and East Europe gives access to patients     and talent, making our service cost competitive.  Quality is built into our service delivery. Our operations are ISO compliant, research sites are ICH GCP    compliant, data management is 21CFR Part 11 compliant and Central Labs are CAP and ISO certified.  US FDA and WHO have audited Phase I studies conducted by us. A number of sponsors have audited our    operations with no major observations. Our studies have been audited by regulators including US FDA and    investigational products have received marketing approval.  High credibility established with European, US and Indian regulators namely FDA, EMEA, BfArM, DCGI    amongst others.  Personalized services and flexibility provided with 265 full time professionals, amongst which 47 are MD's    and Ph D's. We have turned the diversity of cultures into synergistic advantages.

Privacy Policy     Disclaimer